Products - Pulmonary fibrosis | Topic | NICE

Showing 6 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
23 May 2017
Published:
12 June 2013
Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal) (TA1111)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
19 November 2025
Nintedanib for treating idiopathic pulmonary fibrosis (TA379)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 January 2016
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted (TA864)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
1 February 2023
Nintedanib for treating progressive fibrosing interstitial lung diseases (TA747)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
17 November 2021
Pirfenidone for treating idiopathic pulmonary fibrosis (TA504)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
6 February 2018